Why the study?
Human adenovirus type 4 frequently causes epidemics among military and civilian populations.
The increasing incidence of HAdV-E4 infections among civilians highlights a potential need for emergency use authorization of the adenovirus vaccine outside military populations.
Answers are grounded in this paper and cite their sources.
Rising civilian HAdV-E4 cases warrant clinical vigilance; extends surveillance needs beyond military populations.
Human adenovirus type 4 (HAdV-E4) frequently causes epidemics among military and civilian populations. We conducted a systematic review of 144 peer-reviewed articles reporting HAdV-E4 infections, published during the years 1960-2020. More than 24 500 HAdV-E4 infections, including 27 associated deaths, were documented. HAdV-E4 infections were reported from all geographic regions of the world except Central America and the Caribbean. The number of publications reporting civilian infections tripled in the last decade, with a steady increase in reported civilian infections over time. Infections commonly caused respiratory and ocular disease. North America reported the most infections, followed by Asia and Europe. The majority of deaths were reported in the United States, followed by China and Singapore. Civilians seem to increasingly suffer HAdV-E4 disease, with recent epidemics among US college students. Public health officials should consider seeking emergency use authorization for the adenovirus vaccine such that it might be available to mitigate civilian epidemics.
No takes yet. Share an insight, caveat, or question.
Coleman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: